or Try an Advanced Search...

    Technical Analysis for TRML - Tourmaline Bio, Inc.

    Grade Last Price % Change Price Change
    F 15.27 0.13% 0.02
    TRML closed up 5.76 percent on Wednesday, May 15, 2024, on 37 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Flat
    Historical TRML trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.13%
    Bollinger Band Squeeze Range Contraction 0.13%
    Gapped Up Strength 0.13%
    Oversold Stochastic Weakness 0.13%
    Bollinger Band Squeeze Range Contraction 5.89%
    Narrow Range Bar Range Contraction 5.89%
    Stochastic Reached Oversold Weakness 5.89%
    Earnings Movers Other 5.89%
    BB Squeeze + Lower Band Touch Range Contraction 5.89%
    Inside Day Range Contraction 5.89%
    Older End-of-Day Signals for TRML ...

       Recent Intraday Alerts

    Alert Time
    Rose Above 20 DMA about 2 hours ago
    Down 1% about 2 hours ago
    10 DMA Resistance about 3 hours ago
    Rose Above 10 DMA about 4 hours ago
    20 DMA Resistance about 4 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    TRML Chart by TradingView
    Basic chart:

    Profile

    Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune diseases. It develops medicines and therapies for the Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED). The company was incorporated in 2021 and is based in New York, New York.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Medication Thyroid Eye Disease Atherosclerosis Immune Diseases

    Is TRML a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 16 Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial
    May 13 Tourmaline Bio GAAP EPS of -$0.55
    May 13 Tourmaline Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights
    Apr 2 Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
    Mar 22 Tourmaline Bio: Sinking On Rival's Stodgy Data - I'm Slightly Bearish
    Mar 19 Tourmaline Bio GAAP EPS of -$8.87
    Mar 19 Tourmaline Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
    Mar 1 Bullish Tourmaline Bio Insiders Loaded Up On US$643.3k Of Stock
    Feb 27 Tourmaline Bio to Present at Upcoming Investor Conferences
    Feb 1 Tourmaline Bio to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference
    See more TRML news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 48.31
    52 Week Low 9.18
    Average Volume 486,287
    200-Day Moving Average 26.14
    50-Day Moving Average 23.86
    20-Day Moving Average 15.44
    10-Day Moving Average 15.30
    Average True Range 1.27
    RSI (14) 34.21
    ADX 41.17
    +DI 15.18
    -DI 26.79
    Chandelier Exit (Long, 3 ATRs) 15.49
    Chandelier Exit (Short, 3 ATRs) 18.08
    Upper Bollinger Bands 16.38
    Lower Bollinger Band 14.51
    Percent B (%b) 0.4
    BandWidth 12.11
    MACD Line -2.11
    MACD Signal Line -2.61
    MACD Histogram 0.4952
    Fundamentals Value
    Market Cap 310.15 Million
    Num Shares 20.3 Million
    EPS
    Price-to-Sales 0.00
    Price-to-Book 5.25
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 17.14
    Resistance 3 (R3) 17.14 16.52 16.83
    Resistance 2 (R2) 16.52 16.04 16.52 16.72
    Resistance 1 (R1) 15.88 15.74 16.20 15.88 16.61
    Pivot Point 15.26 15.26 15.42 15.26 15.26
    Support 1 (S1) 14.62 14.78 14.94 14.62 13.89
    Support 2 (S2) 14.00 14.48 14.00 13.78
    Support 3 (S3) 13.36 14.00 13.68
    Support 4 (S4) 13.36